National Medicines Policy Review – publication of submissions

21 January 2022 - On 30 August 2021, the National Medicines Policy Review Committee invited submissions to support the Review of ...

Read more →

Australia launches National Preventive Health Strategy

13 December 2021 - The Australian Government has today launched the National Preventive Health Strategy, a 10 year plan to improve ...

Read more →

Canada's national strategy for drugs for rare diseases needs a holistic approach

8 December 2021 - International report summarises drugs for rare disease best practices and recommendations. ...

Read more →

Shining a light on PHARMAC

6 December 2021 - It is encouraging to read the country’s drug buying agency PHARMAC is already moving to improve ...

Read more →

PHARMAC welcomes interim report

 2 December 2021 - PHARMAC accepts many of the observations made in the Interim Report and is already making changes ...

Read more →

What happened to the promise of universal pharmacare?

25 November 2021 - Canada is the only developed country in the world with a universal health care system that ...

Read more →

It’s time to better support the three million Canadians with a rare disease

25 November 2021 - After finding out her private health insurer would no longer pay for a drug helping with ...

Read more →

Bolstering our ability to value health technology: a few less considered issues

9 November 2021 - Proposals for a national entity to produce and assess evidence about the relative value of medical technology ...

Read more →

Universal health care is a fundamental right — being delusional is not

10 November 2021 - Singapore’s Health Ministry has announced that its citizens who choose not to be vaccinated will be ...

Read more →

The evolution of the Italian National Health Service

22 October 2021 - 40 years ago, Italy saw the birth of a national, universal health care system (Servizio Sanitario Nazionale ...

Read more →

Cystic fibrosis medicine added to PHARMAC's options for investment list

27 October 2021 - PHARMAC has announced that Vertex’s triple combination modulator therapy, known in some countries as Trikafta, has ...

Read more →

The challenges of inadequate financial support for Australians with cancer

21 October 2021 - The publicly funded Medicare system in Australia has been recognised as a leading universal health care model. ...

Read more →

Belgium may remove step between paying doctors and reimbursement

8 October 2021 - Doctors and dentists could soon choose to only charge patients for co-payments – the non-refundable part ...

Read more →

Review of the National Medicines Policy

11 October 2021 - The call for submissions closed on Friday 8 October 2021 and a total of 107 submissions have ...

Read more →

Medicare reverses course on decision to universally cover breakthrough medical devices for 4 years

4 October 2021 - In January 2021, in the waning days of the Trump Administration, the CMS finalised a rule ...

Read more →